RecruitingPhase 2NCT07097506

Effect of Ketone Esters on Liver Fat Content and Metabolic Function

Effect of Ketone Esters on Liver Fat and Metabolic Function in Adolescents and Young Adults With Overweight/Obesity and MASLD


Sponsor

Washington University School of Medicine

Enrollment

40 participants

Start Date

Sep 26, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to determine whether ingestion of a ketone ester drink helps improve liver health and blood glucose control. Ketones are a type of energy source made by the body during times of weight loss, low carbohydrate intake and starvation. People enrolled in this study will be randomly assigned (by chance, like the flip of a coin) to one of two groups: Group 1: Ketone ester drink consumed daily for 6 weeks. Group 2: Placebo drink consumed daily for 6 weeks.


Eligibility

Min Age: 18 YearsMax Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Placebo and a drug called bis-octanoyl (R)-1,3-butanediol (C8 ketone di-ester) for people with masld - metabolic dysfunction-associated steatotic liver disease, obesity, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGbis-octanoyl (R)-1,3-butanediol (C8 ketone di-ester)

25 g C8 ketone di-ester taken daily for approximately 6-weeks

OTHERPlacebo

25 g Placebo taken daily for approximately 6-weeks


Locations(1)

Washington University School of Medicine

St Louis, Missouri, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07097506


Related Trials